Clinical Trial Update: Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial investigating SHR-1701 plus BP102 in advanced or metastatic non-squamous non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BP102
• SHR-1701

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN